Document Detail

Long-term efficacy of dextranomer in stabilized hyaluronic acid (NASHA/Dx) for treatment of faecal incontinence.
MedLine Citation:
PMID:  23374680     Owner:  NLM     Status:  Publisher    
AIM: Randomized, controlled trials have demonstrated the efficacy and safety of injectable bulking agents for the treatment of fecal incontinence, although the long-term outcome has not been assessed. NASHA/Dx gel, a biocompatible, nonallergenic bulking agent consisting of nonanimal stabilized hyaluronic acid and dextranomer microspheres, has demonstrated efficacy and safety for up to 12 months after treatment. The objective of this study was to evaluate the long-term efficacy and safety of NASHA/Dx, assessed 24 months after treatment. METHOD: This study was a 24-month follow-up assessment of patients treated with NASHA/Dx under open-label conditions. Data on FI episodes and quality of life measures were collected from diaries over the 28-day period immediately preceding the 24-month assessment. Adverse events were collected. RESULTS: Eighty-three of 115 fifteen patients completed the 24-month follow-up assessment. At 24 months, 62.7% of patients were considered responders and experienced ≥ 50% reduction in total number of FI episodes. The median number of FI episodes declined by 68.8% (P<0.001). Episodes of both solid and liquid stool incontinence decreased. The mean number of incontinence-free days increased from 14.6 at baseline to 21.7 at 24 months (P<0.001). Incontinence scores and FI quality of life scores also showed significant improvements. The most common adverse events (AEs) were proctalgia (13.3%) and pyrexia (9.6%). The majority of AEs were mild to moderate, self-limited, and resolved within 1 month of the injection. CONCLUSION: NASHA/Dx is safe, effective, and durable over a 24-month period with a majority of patients experiencing significant improvement in multiple symptoms associated with FI. © 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland.
F La Torre; F de la Portilla
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-1
Journal Detail:
Title:  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland     Volume:  -     ISSN:  1463-1318     ISO Abbreviation:  Colorectal Dis     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883611     Medline TA:  Colorectal Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland.
Director of Colorectal and Pelvic Surgery, 1st College of Medicine "SAPIENZA" Rome University, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sinonasal inverted papilloma involving the temporal bone via the eustachian tube: case report.
Next Document:  Heterologous expression of Candida albicans Pma1p in Saccharomyces cerevisiae.